Rosenberg SA - Search Results

1

Threshold levels of gene expression of the melanoma antigen gp100 correlate with tumor cell recognition by cytotoxic T lymphocytes.

Riker AI, Kammula US, Panelli MC, Wang E, Ohnmacht GA, Steinberg SM, Rosenberg SA, Marincola FM. Riker AI, et al. Among authors: rosenberg sa. Int J Cancer. 2000 Jun 15;86(6):818-26. doi: 10.1002/(sici)1097-0215(20000615)86:6<818::aid-ijc10>3.0.co;2-w. Int J Cancer. 2000. PMID: 10842196

2

Immune selection after antigen-specific immunotherapy of melanoma.

Riker A, Cormier J, Panelli M, Kammula U, Wang E, Abati A, Fetsch P, Lee KH, Steinberg S, Rosenberg S, Marincola F. Riker A, et al. Surgery. 1999 Aug;126(2):112-20. Surgery. 1999. PMID: 10455872

3

Recognition of multiple epitopes in the human melanoma antigen gp100 by peripheral blood lymphocytes stimulated in vitro with synthetic peptides.

Salgaller ML, Afshar A, Marincola FM, Rivoltini L, Kawakami Y, Rosenberg SA. Salgaller ML, et al. Among authors: rosenberg sa. Cancer Res. 1995 Nov 1;55(21):4972-9. Cancer Res. 1995. PMID: 7585538

4

Loss of functional beta 2-microglobulin in metastatic melanomas from five patients receiving immunotherapy.

Restifo NP, Marincola FM, Kawakami Y, Taubenberger J, Yannelli JR, Rosenberg SA. Restifo NP, et al. Among authors: rosenberg sa. J Natl Cancer Inst. 1996 Jan 17;88(2):100-8. doi: 10.1093/jnci/88.2.100. J Natl Cancer Inst. 1996. PMID: 8537970 Free PMC article.

5

Immunization against epitopes in the human melanoma antigen gp100 following patient immunization with synthetic peptides.

Salgaller ML, Marincola FM, Cormier JN, Rosenberg SA. Salgaller ML, et al. Among authors: rosenberg sa. Cancer Res. 1996 Oct 15;56(20):4749-57. Cancer Res. 1996. PMID: 8840994 Clinical Trial.

6

Heterogeneous expression of melanoma-associated antigens and HLA-A2 in metastatic melanoma in vivo.

Cormier JN, Hijazi YM, Abati A, Fetsch P, Bettinotti M, Steinberg SM, Rosenberg SA, Marincola FM. Cormier JN, et al. Among authors: rosenberg sa. Int J Cancer. 1998 Feb 9;75(4):517-24. doi: 10.1002/(sici)1097-0215(19980209)75:4<517::aid-ijc5>3.0.co;2-w. Int J Cancer. 1998. PMID: 9466650

7

Trends in the safety of high dose bolus interleukin-2 administration in patients with metastatic cancer.

Kammula US, White DE, Rosenberg SA. Kammula US, et al. Among authors: rosenberg sa. Cancer. 1998 Aug 15;83(4):797-805. Cancer. 1998. PMID: 9708948

8

Functional dissociation between local and systemic immune response during anti-melanoma peptide vaccination.

Lee KH, Panelli MC, Kim CJ, Riker AI, Bettinotti MP, Roden MM, Fetsch P, Abati A, Rosenberg SA, Marincola FM. Lee KH, et al. Among authors: rosenberg sa. J Immunol. 1998 Oct 15;161(8):4183-94. J Immunol. 1998. PMID: 9780192

9

Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigens.

Rosenberg SA, Zhai Y, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL, Restifo NP, Seipp CA, Einhorn JH, Roberts B, White DE. Rosenberg SA, et al. J Natl Cancer Inst. 1998 Dec 16;90(24):1894-900. doi: 10.1093/jnci/90.24.1894. J Natl Cancer Inst. 1998. PMID: 9862627 Free PMC article. Clinical Trial.

10

Development and characterization of melanoma cell lines established by fine-needle aspiration biopsy: advances in the monitoring of patients with metastatic melanoma.

Riker AI, Panelli MC, Kammula US, Wang E, Wunderlich J, Abati A, Fetsch P, Rosenberg SA, Marincola FM. Riker AI, et al. Among authors: rosenberg sa. Cancer Detect Prev. 1999;23(5):387-96. doi: 10.1046/j.1525-1500.1999.99045.x. Cancer Detect Prev. 1999. PMID: 10468890

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,359 results

Search Page

Filters